Robot-assisted Surgery with Para-aortic Lymphadenectomy for Endometrial Cancer: A Preliminary Report.

IF 1.4 Q3 OBSTETRICS & GYNECOLOGY

Gynecology and Minimally Invasive Therapy-GMIT Pub Date : 2023-12-07 eCollection Date: 2024-04-01 DOI:10.4103/gmit.gmit_29_23

Shigehiro Hayashi, Junya Kojima, Toru Sasaki, Akiko Yamamoto, Kazuyoshi Kato, Hirotaka Nishi

{"title":"Robot-assisted Surgery with Para-aortic Lymphadenectomy for Endometrial Cancer: A Preliminary Report.","authors":"Shigehiro Hayashi, Junya Kojima, Toru Sasaki, Akiko Yamamoto, Kazuyoshi Kato, Hirotaka Nishi","doi":"10.4103/gmit.gmit_29_23","DOIUrl":null,"url":null,"abstract":"Objectives: There are few reported cases of robot-assisted surgery for endometrial cancer with para-aortic lymphadenectomy (PAL) in Japan. Therefore, this study aimed to examine the clinical outcomes of robot-assisted surgery with PAL for endometrial cancer.Materials and methods: This retrospective cohort study was analyzed 13 endometrial cancer patients who underwent robotic surgery with PAL between January 2011 and October 2018 at our hospital. We examined their perioperative complications and oncological outcomes.Results: The median follow-up period, median overall survival, and disease-free interval were 80 months, 79 months (61-120), and 79 months (5-120), respectively. There were two (15.3%) cases of perioperative complications of Clavien-Dindo Class II or higher and three (23.0%) cases of recurrence.Conclusion: Our results showed that the surgical and oncological outcomes of robot-assisted surgery for endometrial cancer with PAL were comparable with those of other developed countries.","PeriodicalId":45272,"journal":{"name":"Gynecology and Minimally Invasive Therapy-GMIT","volume":"13 2","pages":"95-100"},"PeriodicalIF":1.4000,"publicationDate":"2023-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11192276/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecology and Minimally Invasive Therapy-GMIT","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/gmit.gmit_29_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: There are few reported cases of robot-assisted surgery for endometrial cancer with para-aortic lymphadenectomy (PAL) in Japan. Therefore, this study aimed to examine the clinical outcomes of robot-assisted surgery with PAL for endometrial cancer.

Materials and methods: This retrospective cohort study was analyzed 13 endometrial cancer patients who underwent robotic surgery with PAL between January 2011 and October 2018 at our hospital. We examined their perioperative complications and oncological outcomes.

Results: The median follow-up period, median overall survival, and disease-free interval were 80 months, 79 months (61-120), and 79 months (5-120), respectively. There were two (15.3%) cases of perioperative complications of Clavien-Dindo Class II or higher and three (23.0%) cases of recurrence.

Conclusion: Our results showed that the surgical and oncological outcomes of robot-assisted surgery for endometrial cancer with PAL were comparable with those of other developed countries.

查看原文本刊更多论文

机器人辅助子宫内膜癌主动脉旁淋巴腺切除术：初步报告

目的：在日本，机器人辅助手术治疗子宫内膜癌并行主动脉旁淋巴结切除术（PAL）的病例报道很少。因此，本研究旨在探讨子宫内膜癌机器人辅助手术联合主动脉旁淋巴结切除术的临床效果：这项回顾性队列研究分析了 2011 年 1 月至 2018 年 10 月期间在我院接受 PAL 机器人手术的 13 例子宫内膜癌患者。我们研究了他们的围手术期并发症和肿瘤学结果：中位随访时间、中位总生存期和无病间隔时间分别为80个月、79个月（61-120）和79个月（5-120）。有 2 例（15.3%）围手术期并发症为 Clavien-Dindo II 级或以上，3 例（23.0%）复发：我们的研究结果表明，机器人辅助手术治疗子宫内膜癌（PAL）的手术和肿瘤治疗效果与其他发达国家相当。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Gynecology and Minimally Invasive Therapy-GMIT OBSTETRICS & GYNECOLOGY-

CiteScore

2.00

自引率

16.70%

发文量

审稿时长

52 weeks